Table 1.
Toxoplasma gondii isolates tested for susceptibility to Sulfadiazine and characteristics of the newborns from which the isolates were obtained.
Fig 1.
Survival rates of Swiss mice infected with 104 tachyzoites from T. gondii isolates and treated during 10 days with different doses of sulfadiazine (80, 160, and 320 mg/Kg/day), initiating 48 hours after the inoculum.
Isolates: TgCTBr03 (A), TgCTBr07 (B), TgCTBr08 (C), TgCTBr11 (D) and TgCTBr16. NTC Groups (E): non-treated control groups, infected with the respective isolate.
Table 2.
Bioassay of the surviving mice after infection with T. gondii isolates TgCTBr08, TgCTBr11, and TgCTBr16 and treatment with different doses of SDZ, for verification of cerebral parasitism.
Table 3.
Genotypic and phenotypic profile of 11 Brazilian Toxoplasma gondii isolates with different susceptibilities to sulfadiazine.
Table 4.
Polymorphisms identified in exons of the dhps gene of Toxoplasma gondii.